Immunodominant human T-cell epitopes of hepatitis C virus
US6555114B1 · kind B1 · utility
38Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 1996 |
| Grant date | Apr 29, 2003 |
| Priority date | — |
| Expiry date | Apr 25, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a polypeptide of about 8 to about 100 amino acids containing at least about 8 contiguous amino acids selected from the core, and/or the E1, and/or E2, and/or the NS3 regions of the HCV polyprotein, with the contiguous amino acids containing a T-cell stimulating epitope.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.